Business Description
Obsidian Therapeutics Inc
NAICS : 541714
SIC : 2834
Description
Obsidian Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States that develops engineered cell therapies for solid tumors. The company's proprietary cytoDRiVE platform uses drug-responsive domains to regulate protein function, and its lead programs apply this technology to engineered tumor-infiltrating lymphocyte (TIL) therapies, known as cytoTILs. Its main product candidate, OBX-115, is an autologous, genetically engineered TIL therapy designed to eliminate the need for systemic interleukin-2 administration, and it is being evaluated in clinical trials for melanoma and non-small cell lung cancer. Obsidian also pursues additional engineered cell therapy programs built on its platform. The company operates as a research and development-stage business, funding its activities primarily through equity financing, partnerships, and collaboration arrangements rather than product revenue, and it targets oncology markets in the United States and other regions.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 18.79 | |||||
Equity-to-Asset | -3 | |||||
Debt-to-Equity | -0.02 | |||||
Debt-to-EBITDA | -0.04 | |||||
Interest Coverage | N/A |
N/A
|
N/A
| |||
Piotroski F-Score | N/A/9 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 5.31 | |||||
Quick Ratio | 5.31 | |||||
Cash Ratio | 5.24 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
ROA % | -73.9 | |||||
ROIC % | -590.95 | |||||
ROC (Joel Greenblatt) % | -1327.39 | |||||
ROCE % | -87.75 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 0.11 | |||||
EV-to-EBIT | 8.28 | |||||
EV-to-EBITDA | 8.24 | |||||
EV-to-FCF | -20.73 | |||||
Earnings Yield (Greenblatt) % | 12.08 | |||||
FCF Yield % | -4.64 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:OBX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Obsidian Therapeutics Inc Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | 161.866 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | - | ||
| 14-Day RSI | 35.62 | ||
| 14-Day ATR ($) | 2.543154 | ||
| 20-Day SMA ($) | 17.605 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range ($) | 14.57 - 49.9699 | ||
| Shares Outstanding (Mil) | 61.77 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Obsidian Therapeutics Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Obsidian Therapeutics Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Obsidian Therapeutics Inc Frequently Asked Questions
What is Obsidian Therapeutics Inc(OBX)'s stock price today?
The current price of OBX is $17.33. The 52 week high of OBX is $49.97 and 52 week low is $14.57.
When is next earnings date of Obsidian Therapeutics Inc(OBX)?
The next earnings date of Obsidian Therapeutics Inc(OBX) is .
Does Obsidian Therapeutics Inc(OBX) pay dividends? If so, how much?
Obsidian Therapeutics Inc(OBX) does not pay dividend.
Press Release
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers